메뉴 건너뛰기




Volumn 5, Issue 9, 2015, Pages

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

Author keywords

[No Author keywords available]

Indexed keywords

NIROGACESTAT; NOTCH1 RECEPTOR; 2-(5,7-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-3-YLAMINO)-N-(1-(2-METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE; ANTINEOPLASTIC AGENT; NOTCH1 PROTEIN, HUMAN; TETRALIN DERIVATIVE; VALINE;

EID: 84989350415     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2015.80     Document Type: Letter
Times cited : (99)

References (15)
  • 1
    • 17144474314 scopus 로고    scopus 로고
    • Gene expression signatures define novel oncogenic pathways in t cell acute lymphoblastic leukemia
    • Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
    • (2002) Cancer Cell , vol.1 , pp. 75-87
    • Ferrando, A.A.1    Neuberg, D.S.2    Staunton, J.3    Loh, M.L.4    Huard, C.5    Raimondi, S.C.6
  • 2
    • 40749150603 scopus 로고    scopus 로고
    • Acute lymphoblastic leukaemia
    • Pui CH, Robinson LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008; 371: 1030-1043.
    • (2008) Lancet , vol.371 , pp. 1030-1043
    • Pui, C.H.1    Robinson, L.L.2    Look, A.T.3
  • 3
    • 78649991073 scopus 로고    scopus 로고
    • Notch signaling in t cell lymphoblastic leukemia/lymphoma and other hematological malignancies
    • Aster JC, Backlow SC, Pear WS. Notch signaling in T cell lymphoblastic leukemia/lymphoma and other hematological malignancies. J Pathol 2011; 223: 262-273.
    • (2011) J Pathol , vol.223 , pp. 262-273
    • Aster, J.C.1    Backlow, S.C.2    Pear, W.S.3
  • 4
    • 8544262178 scopus 로고    scopus 로고
    • T cell acute lymphoblastic leukemia/lymphoma: A human cancer commonly associated with aberrant notch1 signaling
    • Pear WS, Aster JC. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol 2004; 11: 426-433.
    • (2004) Curr Opin Hematol , vol.11 , pp. 426-433
    • Pear, W.S.1    Aster, J.C.2
  • 5
    • 33745203104 scopus 로고    scopus 로고
    • Cutll1, a novel human t-cell lymphoma cell line with t(7;9) rearrangement, aberrant notch1 activation and high sensitivity to gamma secretase inhibitors
    • Palomero T, Barnes KC, Real PJ, Glade-Bender JL, Sulis ML, Murty VV et al. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma secretase inhibitors. Leukemia 2006; 20: 1279-1287.
    • (2006) Leukemia , vol.20 , pp. 1279-1287
    • Palomero, T.1    Barnes, K.C.2    Real, P.J.3    Glade-Bender, J.L.4    Sulis, M.L.5    Murty, V.V.6
  • 6
    • 33947214529 scopus 로고    scopus 로고
    • Notch signalling, gamma-secretase inhibitors and cancer therapy
    • Shi I, Wang TL. Notch signalling, gamma-secretase inhibitors and cancer therapy. Cancer Res 2007; 67: 1879-1882.
    • (2007) Cancer Res , vol.67 , pp. 1879-1882
    • Shi, I.1    Wang, T.L.2
  • 8
    • 77953368267 scopus 로고    scopus 로고
    • Evaluation of selective gamma-secretase inhibitor pf-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design
    • Wei P, Walls M, Qiu M, Ding R, Denlinger RH, Wong A et al. Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. Mol Cancer Ther 2010; 9: 1618-1628.
    • (2010) Mol Cancer Ther , vol.9 , pp. 1618-1628
    • Wei, P.1    Walls, M.2    Qiu, M.3    Ding, R.4    Denlinger, R.H.5    Wong, A.6
  • 9
    • 84863786154 scopus 로고    scopus 로고
    • Preclinical analysis of the ?-secretase inhibitor pf-03084014 in combination with glucocorticoids in t-cell acute lymphoblastic leukemia
    • Samon JB, Castillo-Martin M, Hadler M, Ambesi-Impiobato A, Paietta E, Racevskis J et al. Preclinical analysis of the ?-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia. Mol Cancer Ther 2012; 11: 1565-1575.
    • (2012) Mol Cancer Ther , vol.11 , pp. 1565-1575
    • Samon, J.B.1    Castillo-Martin, M.2    Hadler, M.3    Ambesi-Impiobato, A.4    Paietta, E.5    Racevskis, J.6
  • 10
    • 84866431367 scopus 로고    scopus 로고
    • Biomarker and pharmacologic evaluation of the gamma-secretase inhibitor pf-03084014 in breast cancer models
    • Zhang CC, Pavlicek A, Zhang Q, Lira ME, Painter CL, Yan Z et al. Biomarker and pharmacologic evaluation of the gamma-secretase inhibitor PF-03084014 in breast cancer models. Clin Cancer Res 2012; 18: 5008-5019.
    • (2012) Clin Cancer Res , vol.18 , pp. 5008-5019
    • Zhang, C.C.1    Pavlicek, A.2    Zhang, Q.3    Lira, M.E.4    Painter, C.L.5    Yan, Z.6
  • 11
    • 35748972639 scopus 로고    scopus 로고
    • Notch and pi3k-Akt pathways intertwined
    • Gutierrez A, Look AT. NOTCH and PI3K-AKT pathways intertwined. Cancer Cell 2007; 12: 411-413.
    • (2007) Cancer Cell , vol.12 , pp. 411-413
    • Gutierrez, A.1    Look, A.T.2
  • 12
    • 34948908663 scopus 로고    scopus 로고
    • Mutational loss of pten induces resistance to notch1 inhibition in t-cell leukemia
    • Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13: 1203-1210.
    • (2007) Nat Med , vol.13 , pp. 1203-1210
    • Palomero, T.1    Sulis, M.L.2    Cortina, M.3    Real, P.J.4    Barnes, K.5    Ciofani, M.6
  • 13
    • 34548592412 scopus 로고    scopus 로고
    • A phase i clinical trial of the notch inhibitor mk-0752 in patients with t-cell acute lymphoblastic leukemia/lymphoma (t-All) and other leukemias
    • DeAngelo DJ, Stone RM, Silverman LB, Stock W, Attar EC, Fearen I et al. A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias. J Clin Oncol 2006; 24: 6585.
    • (2006) J Clin Oncol , vol.24 , pp. 6585
    • DeAngelo, D.J.1    Stone, R.M.2    Silverman, L.B.3    Stock, W.4    Attar, E.C.5    Fearen, I.6
  • 14
    • 79951516547 scopus 로고    scopus 로고
    • Molecular pathogenesis and targeted therapies for notch1-induced t-cell acute lymphoblastic leukemia
    • Paganin M, Ferrando A. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. Blood Rev 2011; 25: 83-90.
    • (2011) Blood Rev , vol.25 , pp. 83-90
    • Paganin, M.1    Ferrando, A.2
  • 15
    • 84920509474 scopus 로고    scopus 로고
    • A phase i, dose-finding study in patients with advanced solid malignancies of the oral ?-secretase inhibitor pf-03084014
    • Messersmith WA, Shapiro GI, Cleary JM, Jimeno A, Dasari A, Huang B et al. A Phase I, dose-finding study in patients with advanced solid malignancies of the oral ?-secretase inhibitor PF-03084014. Clin Cancer Res 2015; 21: 60-67.
    • (2015) Clin Cancer Res , vol.21 , pp. 60-67
    • Messersmith, W.A.1    Shapiro, G.I.2    Cleary, J.M.3    Jimeno, A.4    Dasari, A.5    Huang, B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.